Dose–Response of Ritonavir on Hepatic CYP3A Activity and Elvitegravir Oral Exposure.
Mathias, A. A.; West, S.; Hui, J.; Kearney, B. P.; Clinical Pharmacology & Therapeutics, 2009, vol. 85, issue 1, p 64, ISSN 00099236. ISBN 15326535.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef